Higher hydration volume may not reduce the risk of contrast-induced nephropathy in patients with chronic kidney disease undergoing percutaneous coronary intervention

被引:0
作者
林温霞
申铁梅
刘勇
谭宁
机构
[1] DepartmentofCardiology,GuangdongCardiovascularInstitute,GuangdongprovincialKeyLaboratoryofCoronaryHeartDiseasePrevention,GuangdongGeneralHospital,GuangdongAcademyofMedicalSciences
关键词
chronic kidney disease; contrast-induced nephropathy; hydration; percutaneous coronary intervention;
D O I
10.16268/j.cnki.44-1512/r.2018.01.005
中图分类号
R692 [肾疾病];
学科分类号
1002 ; 100210 ;
摘要
Background Adequate hydration with isotonic saline is generally recommended to prevent contrast-induced nephropathy(CIN) in patients with chronic kidney disease(CKD). However, there is no well-defined protocol regarding the optimal rate and duration of normal saline administration. Methods Patients with CKD(estimated glomerular filtration rate [e GFR] <60 m L/min/1.73 m2) undergoing PCI with hydration at the speed recommended by the current guidelines(1 m L/kg/h [0.5 ml/kg/h for left ventricular ejection fraction <40% or severe congestive heart failure]) were included in the study(n=631). CIN was defined as an increase in serum creatinine of ≥0.5 mg/d L or 25% from the baseline within 48-72 hours after contrast exposure. Results Individuals with higher adequate hydration(HV/W ratios) were more likely to develop CIN(Q1, Q2, Q3, and Q4: 6.33%, 18.4%,12.5%, and 21.52%, respectively; P=0.001), acute heart failure(5.7%, 6.13%, 9.21%, and 13.92%, respectively;P=0.035). Multivariate analyses showed that higher hydration volume was not significantly associated with a reduced risk of CIN(HV/W ratio Q2 vs. Q1: odds ratio [OR]: 2.36, 95% confidence interval [CI]: 1.08~5.16; Q3 vs. Q1: OR: 1.47, 95% CI: 0.63~3.4; Q4 vs. Q1: OR: 2.32, 95% CI: 1.05~5.11). Conclusion Higher hydration volume may not reduce the risk of contrast-induced nephropathy in patients with CKD undergoing PCI.intravascular hydration volume at routine speed may not decrease the risk of CIN in patients with chronic kidney disease undergoing percutaneous coronary intervention.
引用
收藏
页码:33 / 40
页数:8
相关论文
共 13 条
[11]  
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): A Randomized Comparison of 3 Preventive Strategies[J] . Carlo Briguori,Flavio Airoldi,Davide D’Andrea,Erminio Bonizzoni,Nuccia Morici,Amelia Focaccio,Iassen Michev,Matteo Montorfano,Mauro Carlino,John Cosgrave,Bruno Ricciardelli,Antonio Colombo.Circulation . 2007 (10)
[12]  
A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention[J] . Roxana Mehran,Eve D. Aymong,Eugenia Nikolsky,Zoran Lasic,Ioannis Iakovou,Martin Fahy,Gary S. Mintz,Alexandra J. Lansky,Jeffrey W. Moses,Gregg W. Stone,Martin B. Leon,George Dangas.Journal of the American College of Cardiology . 2004 (7)
[13]   ELIMINATION OF THE NONIONIC X-RAY CONTRAST-MEDIA IODIXANOL AND IOHEXOL IN PATIENTS WITH SEVERELY IMPAIRED RENAL-FUNCTION [J].
NOSSEN, JO ;
JAKOBSEN, JA ;
KJAERSGAARD, P ;
ANDREW, E ;
JACOBSEN, PB ;
BERG, KJ .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1995, 55 (04) :341-350